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NF-κBBackground: Atherosclerosis begins as local inﬂammation of vessels at sites of disturbed ﬂow, where low shear
stress (LSS) leads to mechanical irritation and plaque development and progression. Nuclear enzyme
poly(ADP-ribose) polymerase 1 (PARP-1) is associated with the inﬂammation response during atherosclerosis.
We investigated the role and underlyingmechanism of PARP-1 in LSS-induced inﬂammation in human umbilical
vein endothelial cells (HUVECs).Methods and results: HUVECswere simulated by LSS (0.4 Pa). PARP-1 expression
was inhibited by ABT888 or siRNA. The inducible nitric oxide synthase (iNOS) and intercellular adhesion molec-
ular-1 (ICAM-1) expression was regulated by LSS in a time dependent manner. LSS could increase superoxide
production and 3-nitrotyrosine formation. LSS induced DNA damage as assessed by H2A.X phosphorylation
and comet assay. Compared with cells under static, LSS increased PARP-1 expression and PAR formation via
MEK/ERK signaling pathway. PARP-1 inhibition increased Sirt1 activity through an increased intracellular nico-
tinamide adenine dinucleotide (NAD+) level. Moreover, PARP-1 inhibition attenuated LSS-induced iNOS and
ICAM-1 upregulation by inhibiting nuclear factor kappa B (NF-κB) nuclear translocation and activity, with a re-
duced NF-κB phosphorylation. Conclusions: LSS induced oxidative damage and PARP-1 activation via MEK/ERK
pathway. PARP-1 inhibition restored Sirt1 activity by increasing NAD+ level and decreased iNOS and ICAM-1 ex-
pression by inhibiting NF-κB nuclear translocation and activity as well as NF-κB phosphorylation. PARP-1 played
a fundamental role in LSS induced inﬂammation. Inhibition of PARP-1 might be a mechanism for treatment of
inﬂammation response during atherosclerosis.
© 2012 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Atherosclerosis is a complicated chronic inﬂammation in arteries
resulting from interaction between immune mechanisms and meta-
bolic risk factors [1]. It primarily affects large and medium-sized ar-
teries in a site-speciﬁc manner, with a predilection to the inner wall
of curvatures and outer wall of bifurcations [2]. Numerous studies
suggest that local hemodynamic forces play a major role in regulating
the site-speciﬁc predilection of atherosclerosis, and the most impor-
tant one is called wall shear stress [3].
Wall shear stress is a frictional force exerted parallel to the arterial
wall by the wall shear rate and viscosity of blood [4]. Undisturbed
shear stress (USS) ranges from 0.5 to 1.2 Pa, and values below andad, Qilu Hospital of Shandong
531 8216 9255; fax: +86 531
ang).
-ND license.above this range are thought to indicate low shear stress (LSS) and in-
creased shear stress, respectively [5]. Wall shear stress acts on endo-
thelial cells and leads to activation of various cell signaling
molecules, such as protein kinase C (PKC) and mitogen-activated
protein kinase (MAPK) [6]. LSS promotes mass transport of
atherogenetic substances between the lumen and the arterial wall
to induce atherosclerosis and predicts plaque development [7].
Poly(ADP-ribose) polymerase 1 (PARP-1) is a highly conserved
DNA-binding nuclear enzyme that can be activated by oxidative
DNA damage mainly by ROS [8]. Upon DNA damage, PARP-1 binds
to DNA strand breaks and catalyzes the addition of long branched
chains of poly(ADP-ribose) (PAR, the product of PARP-1) to a number
of nuclear proteins. Excessive activation of PARP-1 leads to intracellu-
lar depletion of NAD and ATP, thus resulting in cellular energy crisis,
irreversible cytotoxicity and cell death [9]. Moreover, PARP-1 is a
co-activator of nuclear factor-κB (NF-κB) and can regulate the expres-
sion of various key inﬂammatory genes, including inducible nitric
oxide synthase (iNOS), intercellular adhesion molecule 1 (ICAM-1),
and vascular cell adhesion molecule 1, all of which are regulated by
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pathogenesis of cardiovascular diseases. Pharmacological inhibition or
genetic deletion of PARP-1 can protect against endothelial dysfunction,
reduce inﬂammation and atherosclerotic plaque size, and promote fac-
tors of plaque stability.
Class III histone deacetylases (HDACs), also called sirtuins or Sirts,
constitute a special group of enzymes that require NAD in their
deacetylation reaction [11]. Sirt1 is a prototype member of the sirtuins
family, which has been implicated in transcriptional silencing, genetic
control of aging, cell metabolism, and calorie restriction-mediated lon-
gevity of the organism [12]. Studies have suggested that Sirt1 can pro-
mote cell survival andmay protect cells against oxidative stress [13,14].
However, previous studies focused on the role of PARP-1 in ox-LDL
induced atherosclerosis, and little was known about the relationship
between PARP-1 and low shear stress. Thus, we aimed to investigate
the role and underlying mechanism of PARP-1 in LSS-induced inﬂam-
mation in HUVECs.
2. Materials and methods
2.1. Cell culture, ﬂow system and gene inhibition
HUVECs (ATCC, USA)were cultured in endothelial cell medium (ECM,
ScienCell, CA, USA) supplemented with 5% fetal bovine serum (FBS),
100 U/ml penicillin, and 100 ug/ml streptomycin at 37 °C up to passage
4 and seeded onto gelatin-coated slides. A parallel-plate ﬂow system
was used to impose LSS (0.4 Pa) [15]. We used SP600125, SB203580,
and U0126 (Cell Signaling Technology, MA, USA) to inhibit the activity
of JNK, p38, and ERK. To inhibit PARP-1 expression, HUVECswere treated
with ABT888 [16] or transiently transfected with siRNA negative control
(si-NC) or si-PARP-1 (GenePharma) in Opti-MEM Medium (Invitrogen,
CA, USA) with use of Lipofectamine 2000 (Invitrogen). Experiments
were performed 24 h after transfection.
2.2. RT-PCR
RNAwas extracted fromHUVECs by use of Trizol (Invitrogen). cDNA
generated by RT-PCRwas analyzed by real-time RT-PCRwith iQ™ SYBR
Green Supermix (Bio-Rad Laboratories, CA, USA). Each sample was ana-
lyzed in triplicate, and expression was normalized to that of GAPDH. The
primers for iNOS were as follows: forward, 5′-GTTCTCAGCCCAACA
ATACAAGA-3′; reverse, 5′-GTGGACGGGTCGATGTCAC-3′; for ICAM-1:
forward, 5′-TTGGAAGCCTCATCCG-3′; reverse, 5′-CAATGTTGCGAGACCC-
3′; and for GAPDH: forward, 5′-AGGTCGGTGTGAACGGATTTG-3′; reverse,
5′-TGTAGACCATGTAGTTGAGGTCA-3′. Ampliﬁcation, detection, and data
analysis involved the use of the iCycler Real-Time PCR system (Bio-Rad
Laboratories).
2.3. Western blot analysis
Protein was extracted from HUVECs. Equal amounts of protein
were separated on 10% SDS-PAGE and electro-transferred onto nitro-
cellulose membrane (Amersham Biosciences, NJ, USA). After being
blocked with 5% non-fat milk for 2 h at room temperature, blots
were washed in TBS-T 3 times for 10 min and incubated with primary
antibodies at 4 °C overnight. The primary antibodies were as follows:
rabbit monoclonal anti-β-actin (1:2000, Cell Signaling Technology),
anti-PAR (1:2000, BD Biosciences, NJ, USA), anti-IkBα (1:1000, Cell Sig-
naling Technology), anti-c-Jun/phospho-c-Jun (1:1000, Cell Signaling
Technology), anti-MAPKAPK-2/phospho-MAPKAPK-2 (1:1000, Cell Sig-
naling Technology), anti-ERK/phospho-ERK (1:1000, Cell Signaling
Technology), anti-H2A.X/phospho-H2A.X (1:1000, Cell Signaling Tech-
nology) and anti-Sirt1 (1:2000, Abcam, MA, USA); rabbit polyclonal
anti-PARP-1 (1:500, Sigma-Aldrich), anti-iNOS (1:200, Abcam, MA,
USA), and anti-NF-κB p65/phospho-NF-κB p65 (Ser536, 1:1000, Cell
Signaling Technology); mouse monoclonal anti-ICAM-1 (1:500; SantaCruz Biotechnology) and anti-3-nitrotyrosine (1:1000, Abcam). After
being washed in TBS-T, membranes were incubated with horseradish
peroxidase-conjugated secondary antibody for 2 h at room temperature.
Signals were detected by enhanced chemiluminescence (Millipore) and
analyzed by use of Image-Pro Plus 6.0.
2.4. Immunoﬂuorescence
HUVECswereﬁxed in 4%paraformaldehyde andpermeabilized in PBS
containing 0.1% Triton X-100. After being blocked with BSA for 30 min,
samples were incubated with the antibodies rabbit anti-NF-κB p65
(1:100, Cell Signaling Technology) overnight at 4 °C. Alexa 488-
conjugated goat anti-rabbit IgG (1:500; Jackson ImmunoResearch) was
used as secondary antibodies. A drop of Prolong Gold anti-fade reagent
with DAPI (Vector Laboratories, CA, USA) was used to seal the coverslip.
Images were acquired by laser scanning confocal microscopy (LSM 710,
Zeiss, Germany). Data were analyzed by use of Image-Pro Plus 6.0.
2.5. O2
− production
To measure O2− production in HUVECs, we used dihydroethidium
(DHE) (Beyotime, Beijing) as described [17]. Shear-preconditioned
and static cells were incubated in 5 μM DHE for 30 min at 37 °C in a
light-protected environment, then washed with ECM without FBS
for 3 times. Fluorescence was acquired by use of Zeiss LSM 710 confo-
cal microscope. Static HUVECs were used as reference samples.
2.6. Sirt1 activity and NAD+ level assay
Sirt1 activity was assessed by SIRT1 Fluorescent Activity Assay Kit
(Enzo Life Sciences) to the manufacturer's instructions with minor
modiﬁcations as previously described [18]. Brieﬂy, 20 μg of cells
were used in adeacetylation assay, with 25 μM of Fluor de Lys-SIRT1
as the substrate. The deacetylation of the substrate was measured
by use of a Varioskan Flash (Thermo Scientiﬁc), with excitation wave-
length set at 360 nm and emission at 460 nm. Intracellular NAD+
levels were measured by using NAD+/NADH Assay Kit (Abcam)
according to the manufacturer's instructions. Brieﬂy, HUVECs were
washed with cold PBS and extracted with NADH/NAD extraction buff-
er by freeze/thaw for two cycles (20 min on ice, then 10 min at room
temperature). Total NAD was detected in a 96-well plate and color
was developed and read at 450 nm by use of a Varioskan Flash (Ther-
mo Scientiﬁc).
2.7. Comet assay
DNA damage induced by LSS was assessed by comet assay using
comet assay kit (Trevigen, MD, USA). The Comet Low Melting Point
agarose was prepared by heating the bottle in a 90–100 °C water
bath for 5 min. Then the bottle was placed in a 37 °C water bath for
at least 20 min to cool. Cells were harvested by scraping in cold PBS,
then centrifuged at 1000 g and the cell pellet was re-suspended in
PBS to 105 cells/ml. The cell suspension (50 μl) was quickly mixed
with 500 μl low melting point agarose, then 50 μl of the mixture
was dropped and spreaded over sample area to ensure complete cov-
erage of the sample area, and allowed to gel at 4 °C. Slides were then
submerged in lysis solution for 40 min at 4 °C. Then the slides were
placed in Alkaline Unwinding Solution and allowed to incubate for
40 min at room temperature. The slides were then placed under fresh-
ly prepared electrophoresis buffer composed of the following: 200 mM
NaOH, 1 mMEDTA, and electrophoresed at 4 °C, for 30 min at 21 V. The
slides were then immersed in dH2O, followed by 70% alcohol for 5 min
and then allowed to air dry. The slides were stained by immersion in
SYBR Green I and photographed under a 40× objective. The slides
were scored using CometScore software v1.5 (TriTek Corporation,
Summerduck, VA).
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EMSAwas performed by using LightShift Chemiluminescent EMSA
kit (Thermo Scientiﬁc) according to the manufacturer's instructions.
Brieﬂy, HUVECs were collected and nuclear proteins were extracted
by nuclear extraction kit (active motif, CA, USA). Single-stranded oli-
gonucleotides containing binding sites of NF-κB (5′-AGTTGAGGGGA
CTTTCCCAGGC-3′) were synthesized and end-labeled with biotin
(BioSune, Shanghai, China). Single-stranded oligonucleotides were
annealed to double-strand probes for EMSA. Nuclear protein (5 μg) was
incubated with 20 fmol biotin-labeled oligonucleotides for 20 min at
room temperature in binding buffer consisting of 50 mM KCl,10 mM
EDTA, 2.5% glycerol, 5 mM MgCl2, 50 ng poly(dI·dC), and 0.05% NP-40.
The speciﬁcity of theNF-κB–DNAbindingwas determined in competition
reactions in which a 200-fold molar excess (4 pmol) of unlabeled oligo-
nucleotide was added. After electrophoresis in 6.5% PAGE using 0.5×
TBE buffer, protein–oligonucleotide complex was electroblotted to a pos-
itively charged nylon membrane. Then transferred DNA was crosslinked
to membrane with a UV lamp for 10 min. After incubation in blocking
buffer for 15 min at room temperature, the membrane was washed and
incubated with substrate equilibration buffer for 10 min at roomFig. 1. Relative mRNA and protein expression of iNOS and ICAM-1 with LSS (0.4 Pa) at variou
and 36 h, mRNA and protein expression of iNOS and ICAM-1 were assessed by RT-PCR and W
expression. (C, D, E) Western blot analysis of iNOS and ICAM-1 protein expression. Values a
Control: cells under static.temperature. Themembranewas then incubatedwith chemiluminescent
substrate for 5 min before being analyzed in ImageQuant LAS 4000 mini
(GE Healthcare).
2.9. Statistical analysis
Data are expressed as mean±SD. SPSS for Windows v.16.0 (SPSS
Inc., Chicago, IL, USA) was used for statistical analysis. Intergroup
comparisons involved 2-tailed Student's t-test or one-way ANOVA
followed by Tukey's test (with equal variances assumed) or Dunnett's
T3 test (with equal variances not assumed). A p value less than 0.05
was considered to indicate statistical signiﬁcance.
3. Results
3.1. Time-dependent regulation of inﬂammatory factors by LSS in HUVECs
HUVECs were stimulated by LSS (0.4 Pa) at various times. LSS had
a time-dependent regulation of iNOS and ICAM-1 expression. With
LSS, the mRNA and protein expression of iNOS began to elevate at
4 h and peaked at 12 h (pb0.05 vs. control), and the expression ofs times in HUVECs. After HUVECs were stimulated by LSS for 0, 4 h, 8 h, 12 h, 16 h, 24 h
estern blot analysis. (A, B) Quantiﬁcation of RT-PCR results of iNOS and ICAM-1 mRNA
re expressed as means±SD from three independent experiments. ⁎pb0.05 vs. control.
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(pb0.05 vs. control, Fig. 1). We used HUVECs stimulated by LSS for
12 h for further experiments.
3.2. LSS increased PARP-1 expression and activity in HUVECs
Weused PARP-1 siRNA and PARP-1 inhibitor ABT888 in the following
experiment. To ensure that effective PARP-1 inhibition was achieved in
target cells, we analyzed PARP-1 expression after addition of siRNA. Com-
pared with the control, PARP-1 expression was signiﬁcantly reduced by
siRNA (pb0.05, Fig. 2A and B). Then we examined the effect of LSS on
PARP-1 expression and activity. Compared with the static cells, PARP-1
expression was signiﬁcantly increased by LSS (pb0.05, Fig. 2C and D).
Moreover, LSS could signiﬁcantly increase PAR formation, while ABT888
or si-PARP-1 attenuated it (pb0.05, Fig. 2C and E).
3.3. O2
− production and 3-NT formation were upregulated by LSS
As O2− and 3-NT can damage DNA which leads to PAR formation,
we detected O2− production and 3-NT formation with LSS stimulationFig. 2. Low shear stress increased PARP-1 expression and PAR formation. HUVECs were sti
formation were determined by Western blot analysis. (A, B) Western blot analysis of PARP-
si-NC: negative siRNA control; si-PARP-1: PARP-1 siRNA. Values are means±SD. ⁎pb0.05 vin HUVECs for 12 h. O2− production and 3-NT formation were signiﬁ-
cantly increased in LSS-stimulated HUVECs, which suggested that LSS
could induce oxidative stress (pb0.05, Fig. 3A to C).
3.4. DNA damage was induced by LSS
DNA damage induced by LSSwas determined by H2A.X phosphoryla-
tion and comet assay.HistoneH2A.X is a variant histonewhich is required
for checkpoint-mediated cell cycle arrest and DNA repair following
double-stranded DNA breaks. Various stimulus induced DNA damage
can result in rapid phosphorylation of H2A.X. LSS signiﬁcantly increased
H2A.X phosphorylation (pb0.05, Fig. 3D and E). Comet assay showed
that there was little DNA in tail of static cells, while LSS could increased
the percentage of DNA in tail (pb0.05, Fig. 3F and G).
3.5. PARP-1 was activated by LSS via MEK/ERK pathway
We then investigated the mechanism of PARP-1 activation (PAR
formation) induced by LSS. LSS could increase the protein expression
of p-c-Jun, p-MAPKAPK-2, and p-ERK compared with static (pb0.05,mulated by LSS for 12 h after PARP-1 inhibition by siRNA, PARP-1 expression and PAR
1 expression. (C, D, E) Western blot analysis of PARP-1 expression and PAR formation.
s. control; #pb0.05 vs. low.
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inhibitor), and U0126 (ERK inhibitor) signiﬁcantly reduced them,
but only MEK/ERK inhibition reduced PAR formation (pb0.05, vs.
low, Fig. 4). The results suggested that the MEK/ERK pathway is in-
volved in LSS induced PARP-1 activation.3.6. Inhibition of PARP-1 attenuated inﬂammatory factors expression
Considering the critical role of the inﬂammatory factors in athero-
genesis, we measured the effect of PARP-1 inhibition on iNOS andFig. 3. LSS increased O2− production and 3-nitrotyrosine (3-NT) formation as well as DN
dihydroethidium (DHE) and nitrotyrosine formation was assessed by Western blot analysis.
tiﬁcation of O2− production (red). Nuclei were labeled with 4′,6-diamidino-2-phenylindole (
ern blot analysis of H2A.X phosphorylation. (F, G) The content of DNA in tail was assessedICAM-1 expression in HUVECs. LSS stimulation markedly increased
iNOS and ICAM-1 expression as compared with static cells (pb0.05,
Fig. 5A to C). After PARP-1 inhibition, iNOS and ICAM-1 expression
was signiﬁcantly reduced (pb0.05, vs. low).3.7. PARP-1 inhibition increased Sirt1 activity by upregulation of NAD+
level
Compared with the static cells, LSS decreased the Sirt1 expression
and activity, while PARP-1 inhibition had no signiﬁcant effect on Sirt1A damage. After LSS stimulation for 12 h, superoxide production was measured by
DNA damage was determined by H2A.X phosphorylation and comet assay. (A, B) Quan-
DAPI) (blue). (C) 3-NT expression was measured byWestern blot analysis. (D, E) West-
by comet assay. Values are means±SD. ⁎pb0.05 vs. control.
Fig. 4. LSS induced PAR formation via MEK/ERK signaling pathway. PAR formation was determined by Western blot analysis after MAPK inhibition before LSS stimulation. (A, B, C) Protein expression of p-c-Jun, p-MAPKAPK-2, p-ERK, and
PAR. SP600125: JNK inhibitor; SB203580: P38 inhibitor; U0126: MEK/ERK inhibitor. (D, E, F) Quantiﬁcation of p-c-Jun, p-MAPKAPK-2 and p-ERK protein expression. (G, H, I) Quantiﬁcation of PAR formation. Values are means±SD from three

















Fig. 5. PARP-1 inhibition reduced iNOS and ICAM-1 expression and increased Sirt1 activity. HUVECs were stimulated by LSS for 12 h after PARP-1 inhibition by siRNA, iNOS, ICAM-1
and Sirt1 expression were determined by Western blot analysis, Sirt1 activity and NAD+ were determined. (A, B, C, D) Western blot analysis of iNOS, ICAM-1, and Sirt1 expression.
(E) Sirt1 activity of HUVECs. (F) NAD+ level in HUVECs. si-NC: negative siRNA control; si-PARP-1: PARP-1 siRNA. Values are expressed as means±SD. ⁎pb0.05 vs. static; #pb0.05 vs.
low.
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of Sirt1 depended on NAD+ concentration, the effect of PARP-1 on
NAD+ was determined. Compared with the control, LSS reduced the
NAD+ concentration, while PARP-1 inhibition by inhibitor or siRNA
restored it (pb0.05, Fig. 5F).
3.8. PARP-1 inhibition reduced LSS-induced inﬂammatory factor expression
by inhibiting NF-κB nuclear translocation and activity as well as NF-κB
phosphorylation
Given that iNOS and ICAM-1 expression depend on NF-κB activa-
tion [19], we wondered whether the negative effect of PARP-1 inhibi-
tion was associated with defective NF-κB activation. Fig. 6A shows
that NF-κB p65 was mostly cytoplasmic before LSS stimulation, but
its localization quickly changed to the nucleus with LSS stimulation.
After PARP-1 inhibition, p65 remained primarily cytoplasmic after
LSS treatment. EMSA result showed that LSS could increase NF-κBactivity, while PARP-1 inhibition reduced it (pb0.05, Fig. 6B). Then
we investigated the underlying mechanism. Western blot analysis
showed that LSS reduced the IκBα expression, while PARP-1 inhibition
had no effect on it (Fig. 6C and D), which suggested that the defect
might reside in the actual translocation of the transcription factor to
the nucleus rather than its association with IκBα. Then we measured
p-p65 level. LSS could signiﬁcantly increase p-p65 level compared
with static controls, and PARP-1 inhibition reduced it (pb0.05, Fig. 6E
and F).
4. Discussion
Atherosclerosis begins with fatty streak formation in an athero-
genic background that is caused by the interaction between systemic
cardiovascular risk factors and local hemodynamic forces such as LSS
[20]. The precise interplay between LSS, vessels and plaque develop-
ment is still obscure. We focused on the potential role and underlying
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increased superoxide production and nitrotyrosine formation as
well as DNA damage. PARP-1 could be activated by LSS via MEK/
ERK-dependent pathway, which resulted in an increased NF-κB acti-
vation and iNOS and ICAM-1 expression. PARP-1 plays a critical role
in LSS-induced inﬂammation through a pathway involving a de-
creased Sirt1 activity and increased inﬂammatory factors expression.
PARP-1 is a DNA repair-associated nuclear enzyme that is activat-
ed in response to DNA damage [21]. It is closely related to various
pathological conditions, including heart failure, ischemia–reperfusion
injury, hypertension, atherosclerosis, and aging [22–24]. Accumulat-
ing evidence suggests that the endothelial dysfunction in atheroscle-
rosis is related to the local formation of ROS near the vascular
endothelium and PARP-1 activation [25]. In our experiment, we
found that LSS increased PARP-1 expression and PAR formation. Inhi-
bition of PARP-1 reduced LSS induced inﬂammation, which meant
PARP-1 played a critical role in LSS induced inﬂammation.
As far as we know, PARP-1 is a DNA damage sensor and can be ac-
tivated by damaged DNA, but few reports have described the connec-
tion between LSS and PARP-1. In our experiment, we demonstrated
that LSS could activate a variety of cell signaling transduction mole-
cules, including ERK, JNK, and p38. The expression and/or activity of
these signaling molecules were signiﬁcantly decreased after applica-
tion of siRNA or inhibitor, but only inhibition of MEK/ERK lead to de-
creased PARP-1 activation induced by LSS. We ﬁrstly showed that LSS
could induce PAR formation through MEK/ERK dependent pathway.
We further investigated the potential mechanisms of PARP-1 in
LSS-induced inﬂammation. As an NAD+-dependent class III histone
deacetylase, Sirt1 functions as a key regulator of stress response and
energy homeostasis by regulating various molecules that were in-
volved in cell survival and energy metabolism. Several studies have
demonstrated the beneﬁcial effects of Sirt1 on endothelial cell biolo-
gy. Ota et al. showed that overexpression of Sirt1 prevented oxidative
stress-induced endothelial senescence, whereas inhibition of Sirt1
had an adverse effect [26]. Mattagajasingh and colleagues demon-
strated that inhibition of Sirt1 attenuated endothelium-dependent
vasodilation in rat arteries because of the enhanced acetylation of en-
dothelial nitric oxide synthase (eNOS) [27]. Furthermore, endothelial
cell-speciﬁc overexpression of Sirt1 decreased atherosclerosis in apo-
lipoprotein E-deﬁcient mice [28]. Our experiments demonstrated that
PARP-1 inhibition had no signiﬁcant effect on Sirt1 expression, but it
remarkably increased Sirt1 activity. Considering the protective effect
of Sirt1, this might be a probable mechanism of protection against in-
ﬂammation by PARP-1 inhibition. Thenwe investigated the underlying
mechanism. As the activity of Sirt1 depended on the intracellular NAD+
concentration, the effect of PARP-1 on NAD+ was determined. As we
expected, compared with the static cells, LSS could decrease the
NAD+ concentration, while PARP-1 inhibition alleviated the effect of
LSS, which suggested that PARP-1 could increase the Sirt1 activity by
upregulation of the NAD+ concentration.
Inﬂammation and inﬂammatory factors are implicated in the
pathogenesis of atherosclerosis, from initiation through progression
and ultimate complications [29]. Many indications suggest a role for
NF-κB in atherosclerosis. The transcription factor NF-κB may play a
critical role in guarding the balance of the atherosclerotic process as a
direct regulator of proinﬂammatory and anti-inﬂammatory genes and
as a regulator of cell survival and proliferation [30]. Hypercholesterol-
emia was shown to induce activated NF-κB associated with a decrease
in NO bioavailability in the initial stages of atherosclerosis in the coro-
nary vasculature [31]. In our experiment, PARP-1 inhibition decreased
iNOS and ICAM-1 expression, which may be another mechanism ofFig. 6. PARP-1 inhibition suppressed LSS induced NF-κB nuclear translocation and activity a
DAPI (blue). Nuclei were labeled with 4′,6-diamidino-2-phenylindole (DAPI) (blue); p65
anti-rabbit second antibody (green). (B) NF-κB activity was assessed by EMSA. (C, D) Wes
level. Values are means±SD. ⁎pb0.05 vs. static control, #pb0.05 vs. low.anti-atherosclerosis by PARP-1 inhibition. We speculated that the re-
duced expression of iNOS and ICAM-1 may be associated with NF-κB.
As we expected, PARP-1 inhibition decreased NF-κB nuclear transloca-
tion and activity. These ﬁndings may support in part the relationship
between PARP-1 and NF-κB. Then we investigated the mechanism(s)
by which PARP-1 inhibition reduced the signal transduction of NF-κB.
Hassa found that PARP-1 acted synergistically with p300 and played
an essential regulatory role in NF-κB-dependent gene expression [32].
The active binding form of NF-κB is composed of various combinations
of members of the NF-κB/Rel family. The NF-κB complex remains inac-
tive in the cytoplasm through interactionwith the inhibitory protein in-
hibitor κB (IκB) that sterically hinders binding of import proteins to the
nuclear localization sequence of the NF-κB subunits. Activation of NF-κB
requires phosphorylation of IκBα by IκBα kinase and subsequent degra-
dation through a common ubiquitin–proteasome pathway [33]. As
shown in Fig. 6, LSS stimulation reduced the protein expression of
IκBα. To our surprise, PARP-1 inhibition had no signiﬁcant effect on
IκBα expression. Accumulating evidences have demonstrated that
after the release of NF-κB from inhibition by IκBα, the phosphorylation
of the p65 subunit is critical for binding to its target sites on DNA [34]. It
was important to determine whether PARP-1 played a role in events
leading to p65 NF-κB phosphorylation. Our results clearly suggested
that PARP-1 inhibition signiﬁcantly decreased the p-p65 level. Howev-
er, the mechanism by which PARP-1 inﬂuences these phosphorylation
events needs further investigation.
In conclusion,we ﬁrstly report that PARP-1 plays a critical role in LSS
induced inﬂammation. PARP-1 can be activated by LSS via MEK/ERK
pathway, and inhibition of PARP-1 pharmacologically or genetically
can protect against LSS-induced inﬂammation by increasing Sirt1 activ-
ity and decreasing inﬂammatory factors expression. PARP-1 inhibition
shed light on new interventions to prevent inﬂammation during
atherogenesis.
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